Principal Pharmacist, Integrating Pharmacy & Medicines Optimisation

The NCL Medicines Optimisation Network (MON) supports the ICS in the safe, effective and economical use of medicines. The Joint Formulary Committee (JFC) is a principal committee within the network, which fulfils the Area Prescribing Committee function and cross-sector clinical governance for medicines. The JFC includes multidisciplinary healthcare professional representation from primary care, provider Trusts (secondary care, tertiary care and mental health) and commissioning organisations. JFC focuses on promoting evidence-based medicine and providing the right care, at the right time and in the right place, specifically related to medicines, to help ensure best outcomes and use of resources in NCL. JFC is responsible for establishing whether new medicines, and new indications for existing medicines, represent a safe, equitable, evidence-based and cost-effective use of medicines. It also coordinates or facilitates the development of medicine pathways, guidelines and
position statements to support medicines optimisation and reduce unwarranted variation., The NCL Shared Care Group (a sub-group of JFC) coordinates the development of shared care guidelines and transfer of prescribing documents to support the seamless transition of medicines at the interface. It is also responsible for maintaining the NCL red list (list of hospital only medicines).

The NCL Medicines Optimisation Board (MOB) is a senior pharmacists' committee responsible for leading improvements in medicines efficiency and pharmacy transformation. Following publication of the NHS Long Term Plan, MOB established an Integrated Pharmacy & Medicines Optimisation (IPMO) programme to transform the pharmacy workforce, medicines safety and medicines value.

Disability Confident
About Disability Confident
A Disability Confident employer will generally offer an interview to any applicant that declares they have a disability and meets the minimum criteria for the job as defined by the employer. It is important to note that in certain recruitment situations such as high-volume, seasonal and high-peak times, the employer may wish to limit the overall numbers of interviews offered to both disabled people and non-disabled people. For more details please go to .

This is a North Central London Integrated Care System wide (NCL ICS) role. It is hosted by UCLH (within the IPMO (Integrating Pharmacy and Medicines Optimisation) Programme Team) and represents all organisations across NCL ICS. The NCL ICS is the collective of all NHS Provider organisations within NCL; working together with the NCL Trusts, Integrated Care Board (ICB), Primary Care Networks, community pharmacies, care homes, local authorities and the voluntary, community and social enterprise sectors to form a health and social care partnership.

NCL and North West London (NWL) Integrated Care Boards (ICB) are currently in the process of merging to become West & North London (WNL) ICB. The job description focuses on the established systems in place for NCL, however the post-folder will need to work collaboratively with the team to support the transition to aligned working for WNL.

The key purpose of this role is to lead the NCL Joint Formulary Committee (JFC), in close collaboration with the NCL JFC Chair and to maintain the sector wide medicines formulary and related clinical pathways. The JFC is a principal committee within the NCL Medicines Optimisation Network, providing cross-sector clinical governance for medicines. JFC focuses on promoting evidence-based medicine and guiding best practice for medicines to help ensure best outcomes and use of resources in NCL. JFC isresponsible for establishing whether new medicines, and new indications for existing medicines, represent a safe, equitable, evidence-based and cost-effective use of medicines.

The post-holder also supports the NCL Interface Prescribing Group to deliver interface prescribing support that promotes safe transition of medicine prescribing across sectors.

Lead the NCL Joint Formulary Committee, in close collaboration with the NCL JFC Chair and team, to develop, implement and maintain a sector wide medicines formulary, medicines pathways and position statements.

Provide secretariat support to the NCL Interface Prescribing Group, to support the safe transition of medicines prescribing at the interface.

The NCL IPMO Programme Team are hosted by University College London Hospitals NHS Foundation Trust (UCLH) on behalf of NCL stakeholders. The offices are based at 250 Euston Road, London. Travel to other NCL sites may be required on occasion. There is an opportunity to work remotely for part of the week.

The team is hosted at UCLH, which has a vision is to deliver top-quality patient care, excellent education, and world-class research. At UCLH, we have a real 'One Team' ethos, and our values - safety, kindness, teamwork and improving, are central to the way we work. This is supported by our staff, who voted us as the #1 NHS Acute Trust to work for in the whole of England.

For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.

We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.

Contribute to the development and delivery of system-wide objectives, as an active member of NCL ICS's pharmacy senior leadership team. This includes supporting the ICS Chief Pharmacist to lead pharmacy integration, medicines optimisation projects and deliver medicines system efficiencies, as NCL ICB merges into WNL ICB.

The NCL IPMO Programme Team are hosted by University College London Hospitals NHS Foundation Trust on behalf of NCL stakeholders. The offices are based at 250 Euston Road, London. Travel to other NCL sites may be required on occasion. There is an opportunity to work remotely for part of the week.

The post is a part-time job share, working alongside the current postholder for 0.4WTE, for up to12 months fixed term (until 31stMarch 2027). Secondments will be considered.